Abstract
Insomnia is defined in the International Classification of Sleep Disorders as “difficulty in initiating and/or maintaining sleep” (1). In primary insomnia, the term insomnia constitutes a diagnostic entity. In other disorders it is considered a symptom and not a primary diagnosis. Insomnia is frequently a component of the symptom complexes of other primary sleep disorders, and is listed among the diagnostic criteria for the following dyssomnias: obstructive sleep apnea (OSA) syndrome, central sleep apnea syndrome, central alveolar hypoventilation syndrome, periodic limb movement disorder (PLMD), and restless legs syndrome (RLS). Disrupted sleep is among the diagnostic criteria for narcolepsy. The complaint of insomnia can also accompany parasomnias, and is listed among the diagnostic criteria for sleep starts and nightmares (1). As in other forms of insomnia, in order to be considered a clinically significant problem, the complaint of sleep disturbance must be associated with adverse daytime consequences such as fatigue, decreased concentration, or irritability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Sleep Disorders Association. (1997) International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester, MN.
Lugaresi, E., Coccagna, G., Gambi, D., Ceroni, G. B., and Poppi, M. (1966) Apropos of some nocturnal myoclonic manifestations. Revue Neurologique 115 (3), 547–555.
Young, T., Palta, M., Dempsey, J., et al. (1993) The occurrence of sleep disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230–1235.
Guilleminault,C., Eldridge, F. L., and Dement, W. C. (1973) Insomnia with sleep apnea: a new syndrome. Science 181 (8), 856–858.
Krakow, B., Melendrez, D., Ferreira, E., et al. (2001) Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 120, 1923–1929.
Guilleminault, C., Palombini, L., Poyares, D., and Chowdhuri, S. (2001) Chronic insomnia, postmenopausal women, and sleep disordered breathing Part 1. Frequency of sleep disordered breathing in a cohort. J. Psychosom. Res. 53, 611–615.
Roehrs, T., Conway, W., Wittig, R., et al. (1985) Sleep-wake complaints in patients with sleep-related respiratory disturbances. Am. Rev. Respir. Dis. 132, 520–523.
Bradley, T. D., McNicholas, W., Rutherford, R., et al. (1986) Clinical and physiological heterogeneity of the central sleep apnea syndrome. Am. Rev. Respir. Dis. 134, 217–221.
Lavigne, G. and Montplaisir, J. (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17, 739–743.
Montplaisir, J.,Boucher, S., Poirer, G., Lavigne, G., Lapierre, O., and Lesperance, P. (1996) Clinical polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov. Disord. 12, 61–65.
Coleman, R., Bliwise, D., Sajben, N., et al. (1988) Epidemiology of periodic movements during sleep. In: Sleep/Wake Disorders, Natural History, Epidemiology and Long Term Evolution (Guilleminault, C. and Lugaresi. E., eds.), Raven Press, New York, NY, 217–229.
Coleman, R., Pollak, C., and Weitzman, E. (1980) Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann. Neurol. 8, 416–421.
Dement, W., Zarcone, V., Varner, V., et al. (1972) The prevalence of narcolepsy. Sleep Res. 1, 148.
Bassetti, C. and Aldrich, M. (1996) Narcolepsy. Neurol. Clin. 14, 545–571.
Billard, M., Besset, A., and Cadilhac, J. (1983) The clinical and polygraphic development of narcolepsy. In: Sleep/Wake Disorders: Natural History, Epidemiology and Long Term Evolution ( Builleminault, C. and Lugaresi, E., eds.), Raven Press, New York, NY, 187–199.
Stepansky, R., Holzinger, B., Schmeiser-Rieder, A., et al. (1998) Austrian dream behavior: results of a representative population survey. Dreaming 8, 23–30.
Ohayon, M., Morselli, P., and Guilleminault, C. (1997) Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep 20, 340–348.
Bastien, C. H. and Morin, C. M. (2000) Familial incidence of insomnia. J. Sleep Res. 9, 49–54.
Remmers, J., deGroot, W., Sauerland, E., et al. (1978) Pathogenesis of upper airway occlusion during sleep. J. Appl. Physiol. 44, 931–938.
Kock, N., Culjkovic, B., Maniak, S., et al. (2002) Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q. Am. J. Hum. Genet. 71, 205–208.
Ondo, W. and Jankovic, J. (1996) Restless legs syndrome: clincoetiologic correlates. Neurology 47, 1435–1441.
Sandyk, R., Bernick, C., Lee, S., et al. (1987) L-dopa in uremic patients with the restless legs syndrome. Int. J. Neurosci. 35, 233–235.
Matthews, W. (1986) Iron deficiency and restless legs. Br. Med. J. 1, 898.
Heimen, E. and Christie, M. (1986) Lithium-aggravated nocturnal myoclonus and restless legs syndrome. Am. J. Psychiatry 143, 1191–1192.
Ware, J., Brown, F., Moorad, P., et al. (1984) Nocturnal myoclonus and tricyclic antidepressants. Sleep Res. 13, 72.
Bakshi, R. (1996) Fluoxetine and restless legs syndrome. J. Neurol. Sci. 142, 151–152.
Mendelson, W. (1996) Are periodic leg movements associated with clinical sleep disturbance. Sleep 19, 219–223.
Montplaisir, J., Nicolas, A., Denesle, R., and Gomez-Mancilla, B. (1999) Restless legs syndrome imiproved by pramipexole: a double-blind randomized trial. Neurology 52, 938–943.
Lin, L., Faraco, J., Li, R., et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 409–412.
Chemelli, R., Willie, J., Sinton, C., et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 409–412.
Ripley, B., Overeem, S., Fujiki, N., et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57, 2253–2258.
Peyron, C., Faraco, J., Rogers, W., et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991–997.
John, J., Wu, M., and Siegel, J. (2000) Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Research Online 3, 23–28.
Cartwright, R. (1979) The nature and function of repetitive dreams: a survey and speculation. Psychiatry 42, 131–137.
Cove-Smith, J. and Kirk, C. (1985) CNS-related side-effects with metropolol and atenolol. Eur. J. Pharmacol. 28, 69–72.
Sharf, B., Moskovitz, C., Lupton, M., et al. (1978) Dream phenomena induced by chronic levodopa therapy. J. Neural. Trams. 43, 143–151.
Lepkifker, W., Dannon, P., Iancu, I., et al. (1995) Nightmares related to fluoxetine treatment. Clin. Neuropharmacol. 18, 90–94.
Hershon, H. (1977) Alcohol withdrawal symptoms and drinking behavior. J. Stud. Alcohol. 38, 953–971.
The International Restless Legs Syndrome Study Group. (1995) Towards a better definition of the restless legs syndrome from the international restless legs syndrome study group. Mov. Disord. 10, 634–642.
Roehrs, T., Papineau, K., Rosenthal, L., and Roth, T. (1999) Ethanol as a hypnotic in insomniacs: self-administration and effects on sleep and mood. Neuropsychopharmacology 20 (3), 279–286.
Ford, D. E. and Kamerow, D. B. (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 226 (11), 1479–1484.
Chesson, A., Hartse, K., Anderson, W. M., et al. (1999) Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 22 (7), 961–968.
US Xyrem Multicenter Study Group. (2002) A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25, 42–49.
Coalson, B. (1995) Nightmare help: treatment of of trauma survivors with PTSD. Psychotherapy 32, 381–388.
Miller, W. and DiPilato, M. (1983) Treatment of nightmares via relaxation and desensitization: a controlled evalustion. J. Consult. Clin. Psychol. 51, 870–877.
Keller, R., et al. (1992) Changes in chronic nightmares after one session of desensitization or rehersal instructions. Am. J. Psychiatry 149, 659–663.
Marquis J. (1991) A report on seventy-eight cases treated by eye movement desensitization. J. Behav. Ther. Exp. Psychiatry 22, 187–192.
Kingsbury, S. J. (1993) Brief hypnotic treatment of repetitive nightmares. Am. J. Clin. Hypn. 35, 161–169.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Duntley, S. (2004). Insomnia in Primary Sleep Disorders. In: Attarian, H.P. (eds) Clinical Handbook of Insomnia. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-662-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-662-1_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-465-4
Online ISBN: 978-1-59259-662-1
eBook Packages: Springer Book Archive